Exicure, Inc. Announces Adjournment of Special Meeting and Information for Reconvened Special Meeting
Exicure (Nasdaq: XCUR) announced the adjournment of its Special Meeting of Stockholders scheduled for August 15, 2024, due to lack of quorum. The meeting will be reconvened on August 19, 2024, at 9:00 a.m. Central Time, and will be held virtually via live audio-only webcast. At the time of adjournment, proxies had been submitted by stockholders representing approximately 49.4% of the outstanding shares entitled to vote, falling short of the required majority.
The record date for voting eligibility remains July 26, 2024. Previously submitted proxies will be valid for the reconvened meeting unless revoked. Stockholders who haven't voted are encouraged to do so via the Internet at www.proxyvote.com or by phone at 1-800-690-6903.
Exicure (Nasdaq: XCUR) ha annunciato il rinvio della sua Riunione Straordinaria degli Azionisti prevista per il 15 agosto 2024, a causa della mancanza di quoram. La riunione sarà riconvocata il 19 agosto 2024, alle 9:00 ora centrale, e si svolgerà virtualmente tramite un webcast audio in diretta. Al momento del rinvio, erano stati presentati dei deleghe da parte degli azionisti che rappresentano circa il 49,4% delle azioni in circolazione aventi diritto di voto, un numero insufficiente per raggiungere la maggioranza richiesta.
La data di registrazione per l'idoneità al voto rimane 26 luglio 2024. Le deleghe precedentemente presentate saranno valide per la riunione riconvocata a meno che non siano revocate. Si incoraggiano gli azionisti che non hanno votato a farlo via Internet su www.proxyvote.com o telefonicamente al 1-800-690-6903.
Exicure (Nasdaq: XCUR) anunció el aplazamiento de su Junta Especial de Accionistas programada para el 15 de agosto de 2024, debido a la falta de quórum. La reunión se volverá a convocar el 19 de agosto de 2024, a las 9:00 a.m. hora central, y se llevará a cabo virtualmente a través de una transmisión en vivo solo de audio. En el momento del aplazamiento, se habían presentado poderes por parte de los accionistas que representan aproximadamente el 49,4% de las acciones en circulación con derecho a voto, lo que no alcanza la mayoría requerida.
La fecha de registro para la elegibilidad para votar sigue siendo el 26 de julio de 2024. Los poderes previamente presentados serán válidos para la reunión reconvocada a menos que sean revocados. Se alienta a los accionistas que no han votado a hacerlo a través de Internet en www.proxyvote.com o por teléfono al 1-800-690-6903.
Exicure (Nasdaq: XCUR)는 2024년 8월 15일로 예정된 주주 특별 회의를 원활하게 진행할 수 없어 연기한다고 발표했습니다. 회의는 2024년 8월 19일 오전 9시(중부 표준시)에 재개될 예정이며, 오디오만 실시간 스트리밍으로 진행됩니다. 연기 당시, 투표권이 있는 발행주식의 약 49.4%를 대표하는 주주들에 의해 위임장이 제출된 상태였으나, 필요로 하는 과반수에 미치지 못했습니다.
투표 자격을 위한 기준일은 2024년 7월 26일로 유지됩니다. 이전에 제출된 위임장은 철회되지 않는 한 재개된 회의에서 유효합니다. 투표하지 않은 주주들은 www.proxyvote.com를 통해 인터넷 상에서 또는 전화 1-800-690-6903에 연락하여 투표할 것을 권장합니다.
Exicure (Nasdaq: XCUR) a annoncé le report de son Assemblée Générale Extraordinaire des Actionnaires prévue pour le 15 août 2024, en raison d'un manque de quorum. La réunion sera reconvoquée le 19 août 2024 à 9h00, heure centrale, et se tiendra virtuellement via un webcast audio en direct. Au moment du report, des procurations avaient été soumises par des actionnaires représentant environ 49,4% des actions en circulation ayant droit de vote, ce qui est insuffisant pour atteindre la majorité requise.
La date d'enregistrement pour l'éligibilité au vote reste le 26 juillet 2024. Les procurations précédemment soumises seront valables pour la réunion reconvoquée à moins d'être révoquées. Les actionnaires qui n'ont pas voté sont encouragés à le faire via Internet à l'adresse www.proxyvote.com ou par téléphone au 1-800-690-6903.
Exicure (Nasdaq: XCUR) hat die Verschiebung seiner außerordentlichen Aktionärsversammlung, die für den 15. August 2024 geplant war, aufgrund mangelnder Beschlussfähigkeit angekündigt. Die Sitzung wird am 19. August 2024 um 9:00 Uhr Central Time wieder einberufen und findet virtuell über einen Live-Audio-Webcast statt. Zum Zeitpunkt der Verschiebung waren von Aktionären Stimmrechtsvollmachten eingereicht worden, die etwa 49,4% der ausstehenden stimmberechtigten Aktien repräsentieren, was nicht ausreicht, um die erforderliche Mehrheit zu erreichen.
Der Stichtag für die Wahlberechtigung bleibt der 26. Juli 2024. Bereits eingereichte Vollmachten sind gültig für die wieder einberufene Sitzung, es sei denn, sie werden widerrufen. Aktionäre, die noch nicht abgestimmt haben, werden ermutigt, dies über das Internet unter www.proxyvote.com oder telefonisch unter 1-800-690-6903 zu tun.
- None.
- Failure to achieve quorum for Special Meeting, indicating potential lack of shareholder engagement
- Delay in decision-making process due to meeting adjournment
- Only 49.4% of outstanding shares represented, suggesting possible difficulty in passing proposals
The presence, in person, by remote communication or by proxy, of the holders of a majority of the outstanding shares of stock entitled to vote constitutes a quorum. There was less than the required majority represented at the Special Meeting, so a quorum did not exist. At the time the Special Meeting was adjourned, proxies had been submitted by stockholders representing approximately
The Special Meeting will be reconvened on August 19, 2024 at 9:00 a.m. Central Time and will continue to be held virtually and exclusively online via live audio-only webcast at www.virtualshareholdermeeting.com/XCUR2024SM.
The record date for determination of stockholders entitled to vote at the reconvened Special Meeting remains July 26, 2024.
Proxies previously submitted in respect of the Special Meeting will be voted at the adjourned Special Meeting unless properly revoked, and stockholders who have previously submitted a proxy or otherwise voted need not take any action.
Stockholders who have not yet voted are encouraged to vote as soon as possible via the Internet at www.proxyvote.com or by phone at 1-800-690-6903. You will be asked to provide the control number from your proxy card and follow the instructions.
If you are a beneficial owner of shares registered in the name of your broker, bank or other agent, you should have received these proxy materials and a voting instructions from that organization rather than from us. Simply follow the instructions to ensure that your vote is counted.
About Exicure
Exicure, Inc. has historically been an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. Following its recent restructuring and suspension of clinical and development activities, the Company is exploring strategic alternatives to maximize stockholder value, both with respect to its historical biotechnology assets and more broadly. For further information, see www.exicuretx.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240815834739/en/
Josh Miller
847-673-1700
media@exicuretx.com
Source: Exicure, Inc.
FAQ
When is Exicure's (XCUR) reconvened Special Meeting of Stockholders?
Why was Exicure's (XCUR) Special Meeting adjourned on August 15, 2024?
How can shareholders vote for Exicure's (XCUR) reconvened Special Meeting?
What is the record date for Exicure's (XCUR) reconvened Special Meeting?
